-
公开(公告)号:AU2016281225B2
公开(公告)日:2020-10-15
申请号:AU2016281225
申请日:2016-06-14
Applicant: UBE INDUSTRIES
Inventor: IWASE NORIAKI , AGA YASUHIRO , USHIYAMA SHIGERU , KONO SHIGEYUKI , SUNAMOTO HIDETOSHI , MATSUSHITA TAKASHI , OGI SAYAKA , UMEZAKI SATOSHI , KOJIMA MASAHIRO , ONUMA KAZUHIRO , SHIRAISHI YUSUKE , OKUDO MAKOTO , KIMURA TOMIO
IPC: C07F7/10 , A61K31/695 , A61P1/04 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P35/00 , A61P37/00 , A61P43/00 , C07F7/12
Abstract: The present invention provides a compound represented by general formula (Ia) or a pharmacologically acceptable salt thereof. In general formula (Ia), the two R each independently represent a C
-
公开(公告)号:AU2015337607B2
公开(公告)日:2020-04-09
申请号:AU2015337607
申请日:2015-10-30
Applicant: UBE INDUSTRIES
Inventor: AGA YASUHIRO , USHIYAMA SHIGERU , IWASE NORIAKI , KONO SHIGEYUKI , SUNAMOTO HIDETOSHI , MATSUSHITA TAKASHI , OGI SAYAKA , TANAKA MASAYUKI , MATOYAMA MASAAKI , UMEZAKI SATOSHI , SHIRAISHI YUSUKE , ONUMA KAZUHIRO , KOJIMA MASAHIRO , NISHIYAMA HAYATO , KIMURA TOMIO
Abstract: A compound represented by general formula (I) [in the formula, L
-
公开(公告)号:RU2689315C2
公开(公告)日:2019-05-27
申请号:RU2017102513
申请日:2015-06-26
Applicant: UBE INDUSTRIES
Inventor: IWASE NORIAKI , NISHIDA HIROSHI , OKUDO MAKOTO , ITO MASAAKI , KONO SHIGEYUKI , MATOYAMA MASAAKI , USHIYAMA SHIGERU , OKANARI EIJI , MATSUNAGA HIROFUMI , NISHIKAWA KENJI , KIMURA TOMIO
IPC: C07D333/36 , A61K31/381 , A61P1/16 , A61P11/00 , A61P13/12
Abstract: Изобретениеотноситсяк солямтиофеновогосоединения, замещенногоα-галогеном, общейформулы(I):(где R представляетсобойатомводородаилиметоксигруппу; X представляетсобойатомгалогена; A выбранизгруппы, состоящейиз:;M представляетсобойщелочнойилищелочноземельныйметалл; и n равен 1, когда M представляетсобойщелочнойметалл, иравен 2, когда M представляетсобойщелочноземельныйметалл), котороеобладаетсильным LPA рецепторнымантагонистическимдействием. 8 н. и 7 з.п. ф-лы, 1 табл., 45 пр.
-
公开(公告)号:CA2860601C
公开(公告)日:2016-07-05
申请号:CA2860601
申请日:2013-01-04
Applicant: DAIICHI SANKYO CO LTD , UBE INDUSTRIES
Inventor: KAWAI YUKINORI , IWASE NORIAKI , KIKUCHI OSAMU , TAKATA KATSUNORI , MOTOYAMA TAKAHIRO , HAGIHARA MASAHIKO
IPC: C07D401/14 , A61K31/506 , A61P3/04 , A61P3/06 , A61P9/00 , A61P9/10
Abstract: The present invention provides a salt of a substituted pyridine compound which has excellent CETP inhibition activity and is useful as a medicament. The present invention provides a salt of a compound represented by general formula (I): (see formula I) wherein R1 is optionally substituted alkoxy or the like.
-
公开(公告)号:CA2804924C
公开(公告)日:2016-06-28
申请号:CA2804924
申请日:2011-07-08
Applicant: DAIICHI SANKYO CO LTD , UBE INDUSTRIES
Inventor: NAKAMURA TSUYOSHI , NAMIKI HIDENORI , TERASKA NAOKI , SHIMA AKIKO , HAGIHARA MASAHIKO , IWASE NORIAKI , TAKATA KATSUNORI , KIKUCHI OSAMU , TSUBOIKE KAZUNARI , SETOGUCHI HIROYUKI , YONEDA KENJI , SUNAMOTO HIDETOSHI , ITO KOJI
IPC: C07D401/14 , A61K31/506 , A61K31/5377 , A61K31/541 , A61P3/04 , A61P3/06 , A61P9/10 , A61P43/00
Abstract: Disclosed is a substituted pyridine compound that has excellent CETP inhibiting activity and is useful as a pharmaceutical, or a pharmacologically acceptable salt thereof. Specifically disclosed is a compound, etc., that fulfills a general formula (I) (wherein, R1: H, substitutable alkyl, OH, optionally substituted alkoxy, alkylsulfonyl, optionally substituted amino, carboxy, optionally substituted carbonyl, CN, halogen, optionally substituted phenyl, optionally substituted aromatic heterocyclyl, optionally substituted saturated heterocyclyl, optionally substituted saturated heterocyclyloxy, optionally substituted saturated heterocyclylcarbonyl, etc.)
-
公开(公告)号:CA2966164A1
公开(公告)日:2016-05-06
申请号:CA2966164
申请日:2015-10-30
Applicant: UBE INDUSTRIES
Inventor: AGA YASUHIRO , USHIYAMA SHIGERU , IWASE NORIAKI , KONO SHIGEYUKI , SUNAMOTO HIDETOSHI , MATSUSHITA TAKASHI , OGI SAYAKA , TANAKA MASAYUKI , MATOYAMA MASAAKI , UMEZAKI SATOSHI , SHIRAISHI YUSUKE , ONUMA KAZUHIRO , KOJIMA MASAHIRO , NISHIYAMA HAYATO , KIMURA TOMIO
Abstract: A compound represented by general formula (I) [in the formula, L1 represents an optionally substituted C1-6 alkylene group or the like, L2 represents a single bond or the like, L3 represents a single bond or the like, R1, R2 and R3 each independently represent an optionally substituted C1-4 alkyl group or the like, R4 represents a hydrogen atom or the like, and R5 represents a hydrogen atom or the like] or a pharmacologically acceptable salt thereof.
-
公开(公告)号:MX2015008479A
公开(公告)日:2015-09-23
申请号:MX2015008479
申请日:2013-12-27
Applicant: UBE INDUSTRIES
Inventor: KIMURA TOMIO , USHIYAMA SHIGERU , IWASE NORIAKI , NISHIDA HIROSHI , OKUDO MAKOTO , ITO MASAAKI , KONO SHIGEYUKI , MATOYAMA MASAAKI , OKANARI EIJI , MATSUNAGA HIROFUMI , NISHIKAWA KENJI
IPC: C07D333/36 , A61K31/381 , A61K31/427 , A61K31/443 , A61P13/00 , A61P25/00 , A61P29/00 , A61P35/00 , A61P37/02 , A61P43/00 , C07D409/04 , C07D409/14 , C07D417/12
Abstract: Un compuesto de tiofeno sustituido con halógeno-a novedoso o una sal farmacológicamente aceptable del mismo, que tiene una potente actividad receptor-antagonista de LPA y es útil como un medicamento es proporcionado; un compuesto representado por la fórmula general (I) en donde A representa, un anillo fenilo, un anillo tiofeno o un anillo isotiazol; R1 es el mismo o diferente y representa un átomo de halógeno o un grupo alquilo de C1-C3 R2 representa un átomo de hidrógeno o un grupo alquilo de C1-C6 p representa un número entero de 0 a 5; V representa CR3 en donde R3 representa un átomo de hidrógeno, un grupo amino, un grupo nitro o un grupo alcoxi de C1-C3, o V representa un átomo de nitrógeno; y X representa un átomo de halógeno, o una sal del mismo.
-
公开(公告)号:AU2011274903A1
公开(公告)日:2013-02-14
申请号:AU2011274903
申请日:2011-07-08
Applicant: DAIICHI SANKYO CO LTD , UBE INDUSTRIES
Inventor: NAKAMURA TSUYOSHI , NAMIKI HIDENORI , TERASAKA NAOKI , SHIMA AKIKO , HAGIHARA MASAHIKO , IWASE NORIAKI , TAKATA KATSUNORI , KIKUCHI OSAMU , TSUBOIKE KAZUNARI , SETOGUCHI HIROYUKI , YONEDA KENJI , SUNAMOTO HIDETOSHI , ITO KOJI
IPC: C07D401/14 , A61K31/506 , A61K31/5377 , A61K31/541 , A61P3/04 , A61P3/06 , A61P9/10 , A61P43/00
Abstract: Disclosed is a substituted pyridine compound that has excellent CETP inhibiting activity and is useful as a pharmaceutical, or a pharmacologically acceptable salt thereof. Specifically disclosed is a compound, etc., that fulfills a general formula (I) (wherein, R
-
公开(公告)号:AU2007205452A1
公开(公告)日:2007-07-19
申请号:AU2007205452
申请日:2007-01-16
Applicant: UBE INDUSTRIES
Inventor: OKUDO MAKOTO , SHIGETOMI MANABU , KANDA TOMOKO , HAGIHARA MASAHIKO , NAKANISHI TAKAYUKI , KATSUBE TETSUSHI , IWASE NORIAKI , TANAKA MASAYUKI
IPC: C07D487/04 , A61K31/5025 , A61P1/00 , A61P1/18 , A61P9/00 , A61P11/00 , A61P13/12 , A61P29/00 , A61P31/00 , A61P43/00
Abstract: The present invention discloses a pyrrolopyridazinone compound represented by the formula (1): wherein R 1 represents C 1 -C 2 alkyl group or halogeno C 1 -C 2 alkyl group, R 2 repersents C 3 -C 5 cycloalkyl group, (C 3 -C 5 cycloalkyl)C 1 -C 2 alkyl group or C 1 -C 3 alkyl group, R 3 represents hydrogen atom, or methylene group or cis-vinylene group for forming substituted oxygen-containing hetero ring in combination with group -O-R 2 , R 4 represents hydrogen atom, halogen atom, C 1 -C 8 alkyl group, C 2 -C 6 alkenyl group, C 2 -C 6 alkynyl group, hydroxy C 3 -C 6 alkenyl group, hydroxy C 3 -C 6 alkynyl group, C 1 -C 6 alkyl group substituted by substituent(s) selected from Substituent group (a), C 3 -C 6 cycloalkyl group which may be substituted by substituent(s) selected from Substituent group (b), "C 1 -C 3 alkyl group which is substituted by C 3 -C 6 cycloalkyl group which may be substituted by substituent(s) selected from Substituent group (b), and which may be substituted by a hydroxy group", an aromatic ring group or heteroaromatic ring group each of which may be substituted by a substituent(s) selected from Substituent group (c) or "C 1 -C 2 alkyl group which is substituted by aromatic ring group or heteroaromatic ring group each of which may be substituted by group(s) selected from Substituent group (c), and which may be substituted by a hydroxy group", Substituent group (a) represents a halogen atom, hydroxy group, cyano group, carboxy group, C 1 -C 5 alkoxy group, halogeno C 1 -C 4 alkoxy group, C 3 -C 6 cycloalkoxy group, (C 3 -C 6 cycloalkyl) C 1 -C 2 alkoxy group, C 1 -C 4 alkoxycarbonyl group, C 2 -C 4 alkanoyl group, C 2 -C 4 alkanoyloxy group or C 1 -C 4 alkyl-substituted amino group, Substituent group (b) represents a hydroxy group or a halogen atom, Substituent group (c) represents a halogen atom, a hydroxy group, a cyano group, a nitro group, a carboxy group, C 1 -C 5 alkoxy group, C 1 -C 4 alkoxycarbonyl group, C 2 -C 4 alkanoyloxy group, C 1 -C 4 alkyl-substituted amino group or a C 1 -C 4 alkyl group which may be substituted by a substituent(s) selected from the group consisting of (a halogen atom, a hydroxy group and a carboxy group), or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:MX369801B
公开(公告)日:2019-11-21
申请号:MX2015008479
申请日:2013-12-27
Applicant: UBE INDUSTRIES
Inventor: KIMURA TOMIO , USHIYAMA SHIGERU , IWASE NORIAKI , NISHIDA HIROSHI , OKUDO MAKOTO , ITO MASAAKI , KONO SHIGEYUKI , MATOYAMA MASAAKI , OKANARI EIJI , MATSUNAGA HIROFUMI , NISHIKAWA KENJI
IPC: C07D333/36 , A61K31/381 , A61K31/427 , A61K31/443 , A61P13/00 , A61P25/00 , A61P29/00 , A61P35/00 , A61P37/02 , A61P43/00 , C07D409/04 , C07D409/14 , C07D417/12
Abstract: Un compuesto de tiofeno sustituido con halógeno-a novedoso o una sal farmacológicamente aceptable del mismo, que tiene una potente actividad receptor-antagonista de LPA y es útil como un medicamento es proporcionado; un compuesto representado por la fórmula general (I) en donde A representa, un anillo fenilo, un anillo tiofeno o un anillo isotiazol; R1 es el mismo o diferente y representa un átomo de halógeno o un grupo alquilo de C1-C3 R2 representa un átomo de hidrógeno o un grupo alquilo de C1-C6 p representa un número entero de 0 a 5; V representa CR3 en donde R3 representa un átomo de hidrógeno, un grupo amino, un grupo nitro o un grupo alcoxi de C1-C3, o V representa un átomo de nitrógeno; y X representa un átomo de halógeno, o una sal del mismo.
-
-
-
-
-
-
-
-
-